Services
Company
Legal and Governance
Publication Library / Publications
Cost-effectiveness of Mavacamten for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy using a French healthcare perspective
No abstract available.
Authors
F-E Cotté, M Hurst, S Akarkoub, M Ho, J Vernon, L Chambry, S Leproust
Journal
The European journal of health economics : HEPAC : health economics in prevention and care
Therapeutic Area
Cardiology
Center of Excellence
Health Economic Modeling & Meta-analysis
Year
2025
Read full article